Saturday 17 October 2026
Export WORX’s income statement to Excel — free account
SCWorx Corp.
WORX Healthcare Health Information Services
SCWorx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 3.75% from fiscal 2024. In the quarter to June 2026, revenue grew 3.43%, EPS grew 98.4% and free cash flow grew 88.0%, each against the same quarter a year earlier.
1.40
0.61
−30.35%
Follow WORX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.29 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.13 | 0.69 | 0.47 | 0.88 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(65.80) | (7.93) | (10.42) | (6.88) | |
P/B ratio |
0.05 | 0.28 | 0.19 | 0.41 | |
Price to Tangible BV |
0.40 | 1.79 | 1.04 | 15.91 | |
EV/Sales |
(0.21) | 0.32 | (0.01) | 0.74 | |
EV/EBITDA |
0.00 | 0.52 | 0.00 | 1.49 | |
EV/Operating CF |
0.83 | (0.67) | 0.02 | (1.32) | |
EV/FCF |
0.68 | (0.63) | 0.02 | (1.26) | |
Quick Ratio |
1.97 | 2.28 | 2.63 | 1.10 | |
Current Ratio |
2.19 | 2.53 | 2.72 | 1.13 | |
Net Debt/EBITDA |
10.52 | 13.31 | 16.41 | (0.75) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.03% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.41 | 0.39 | 0.40 | 0.41 | |
Operating CF/Net income |
0.05 | 1.45 | 0.17 | 0.27 | |
Capex/Depreciation |
(90.75) | (1.86) | (0.33) | 0.00 | |
Interest Coverage |
— | (3.57) | (1.42) | (0.12) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.22% | 47.08% | 52.88% | 46.90% | |
Intangible Assets out of Total Assets |
0.78 | 0.76 | 0.74 | 0.81 | |
Share Based Compensation of Revenue |
0.52% | 1.66% | 7.96% | 0.00% | |
Graham Net Nets |
2.46 | 0.55 | 0.95 | 0.06 | |
Graham Number |
158.58 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
342.81% | (295.59%) | (330.67%) | (331.89%) | |
Free Cash Flow Yield |
(243.21%) | (74.11%) | (115.39%) | (66.29%) | |
Revenue per Share |
7.91 | 8.43 | 19.03 | 14.95 | |
Operating CF per Share |
(0.06) | (2.86) | (3.20) | (7.58) | |
Capex per Share |
(0.81) | (0.74) | (0.76) | 0.00 | |
Free Cash Flow per Share |
(0.88) | (3.60) | (3.95) | (7.58) | |
Cash per Share |
14.15 | 15.18 | 40.70 | 14.50 | |
Shareholders Equity per Share |
77.63 | 79.75 | 177.04 | 127.06 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
77.63 | 79.75 | 177.04 | 127.06 | |
Free Cash Flow |
(0.08) | (0.32) | (0.16) | (0.36) | |
Working Capital |
0.92 | 1.11 | 1.28 | 0.16 | |
Capital Expenditures |
(0.07) | (0.07) | (0.03) | — | |
Net Current Asset Value |
0.92 | 1.11 | 1.28 | 0.15 | |
EV/EBIT |
1.05 | 0.00 | 0.03 | 0.00 | |
Capex to Sales |
0.10 | 0.09 | 0.04 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.34 | 0.24 | 0.34 | 0.58 | |
Average Payables |
0.75 | 0.83 | 0.99 | 1.27 | |
Average Assets |
7.18 | 7.47 | 7.12 | 6.85 | |
Average Common Equity |
6.19 | 6.32 | 5.82 | 5.24 |
Columns are period end dates